Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centrica PLC Director's Dealing 2024

Jul 12, 2024

5292_dirs_2024-07-12_9424ea00-37ce-4a1d-a879-db98436d700c.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 3020W

Centrica PLC

12 July 2024

Centrica plc (the "Company")

12 July 2024

Notification of Transactions of Directors

The Company announces  the following transactions on 12 July 2024 in respect of the Company's Ordinary Shares of 6 14/81 pence ("Shares").

The following notification, made pursuant to Article 19 of the Market Abuse Regulation, provides further details. 

Vesting of Award - Long Term Incentive Plan

Awards granted under Centrica plc's Long Term Incentive Plan ("LTIP") on 14 June 2021 vested today, 12 July 2024.

As reported in the Company's 2023 Annual Report and Accounts, the vesting of the award was subject to the satisfaction of performance conditions assessed over the three-year period from 1 January 2021 to 31 December 2023. The vesting outcome was 85% of the original award.

Following the sale of Shares to cover statutory withholding liabilities, the remaining Shares will be held for a mandatory two-year holding period.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name(s)

Chris O'Shea

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

Identification code

Ordinary Shares of 6 14 /81  pence

GB00B033F229

b)

Nature of the transaction

Vesting on 12 July 2024 of nil cost conditional award granted on 14 June 2021 under the LTIP.

c)

Price(s) and volume(s)

Number of Shares vested Price (£)
3,993,838 Nil

d)

Aggregated information

-        Aggregated volume

-        Price

3,993,838

Nil

e)

Date of the transaction

12 July 2024

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

Identification code

Ordinary Shares of 6 14 /81  pence

GB00B033F229

b)

Nature of the transaction

Sale of Shares to cover statutory withholding liabilities. The remaining Shares are subject to a mandatory two-year holding period.

c)

Price(s) and volume(s)

Number of Shares sold to cover statutory withholding liabilities Sale Price (£)
1,880,866 £1.38419

d)

Aggregated information

-        Aggregated volume

-        Price

1,880,866

£1.38419

e)

Date of the transaction

12 July 2024

f)

Place of the transaction

London Stock Exchange (XLON)

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGPUAWMUPCGQP